mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |